StockSelector.com
  Research, Select, & Monitor Monday, April 23, 2018 3:26:16 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Cytori Therapeutics Inc$0.28   

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Cytori Therapeutics Inc has an overall rank of 5964 out of 6819 stocks based on 7 positive rankings and 8 negative rankings.

Positive Rankings
Target Prices
The average analysts' target price is $1.65 for Cytori Therapeutics Inc using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, Cytori Therapeutics Inc is ranked 9.
Estimated Revenue Growth
Cytori Therapeutics Inc rank is 47
Low Put/Call
Cytori Therapeutics Inc has a low Put/Call ratio of 0.05 on all open interest of options expiring in the next 90 days. A low put-to-call ratio indicates there are more bullish investors than bearish investors for the stock. Among companies with a low Put/Call Ratio, Cytori Therapeutics Inc is ranked 122.
Low/Rising MACD
The MACD remains negative, but is rising... suggesting a possible near-term correction. Of companies with a negative, but rising MACD, Cytori Therapeutics Inc is ranked 823.
Price-to-Book
Cytori Therapeutics Inc rank is 1133
90 Day Gain
Cytori Therapeutics Inc rank is 1212
10 Day Gain
Cytori Therapeutics Inc rank is 2282
Negative Rankings
Negative Cash Growth
Cytori Therapeutics Inc rank is 80
Negative Revenue Growth
Cytori Therapeutics Inc rank is 140
Negative ROE
Cytori Therapeutics Inc rank is 156
Negative Net Margin
Cytori Therapeutics Inc rank is 176
Negative ROA
Cytori Therapeutics Inc rank is 322
Price-to-Sales
Cytori Therapeutics Inc rank is 813
High vPut/Call
Cytori Therapeutics Inc has a high Put/Call ratio of 1.16 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Cytori Therapeutics Inc is ranked 969.
Debt-to-Equity
Cytori Therapeutics Inc rank is 2052







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2018 StockSelector.com. All rights reserved.